Interim Report Q1 2022

A broader and stronger licensing business strengthens our position in infection prevention

  • Revenue 55.2 MSEK (41.8)
  • EBITDA -4.0 MSEK (1.9)
  • Cash flow -11.9 MSEK (-0.9)
Read the report
Bactiguard’s Annual Report 2021 <br /> - Accceleration with<br /> the patient in focus

Bactiguard’s Annual Report 2021
- Accceleration with
the patient in focus

A broader and stronger licensing business strengthens our position in infection prevention

Bactiguard Holding AB (publ) published the interim report for the first quarter of 2022 on Wednesday, April 27, 2022, at 08.00 and holds the Annual General Meeting via postal vote on April 29, 2022.

In connection with this, an audiocast for shareholders, investors and analysts was held at 11:00 CET on April 27. CEO Anders Göransson and CFO Gabriella Björknert Caracciolo presented the interim report and answered questions.

Presentation

A broader and stronger licensing business strengthens our position in infection prevention

Exciting future for Bactiguard with CEO
Anders Göransson

Bactiguard’s CEO Anders Göransson speaks with excitement about the future of the company and the growth journey that lays ahead. “Hearing the great feedback from our partners and patients makes me realise that I made the right choice to join Bactiguard”, says Anders Göransson.

Read the interview where Anders Göransson shares his thoughts on where he sees the company heading and what he thinks makes a great leader.

 

Interim Report Q1 2022

Bactiguard Holding AB (publ) published the interim report for the first quarter of 2022 on Wednesday, April 27, 2022, at 08.00 and holds the Annual General Meeting via postal vote on April 29, 2022.

Investor Relations

Gabriella Björknert Caracciolo
Gabriella Björknert Caracciolo
CFO and deputy CEO

Employed 2020

Born: 1970

Education: MBA Stockholm university

Background: Senior positions within SEB and Nordea, experience from Management Consulting

Other assignments: –

Shareholdings: 6,000 B shares as personal holdings

Contact us